Complement-fixing antigen of human cytomegaloviruses

Area of Science:

• Virology
• Immunology
• Molecular Biology

Background:

• Human cytomegalovirus (CMV) is a significant pathogen.
• Understanding CMV antigens is crucial for diagnostics and therapeutics.
• Complement-fixing (CF) antigens are important serological markers.

Purpose of the Study:

• To characterize the stability and molecular properties of human CMV CF antigen.
• To identify specific polypeptides associated with human CMV CF antigen.
• To compare human CMV CF antigen with related viruses.

Main Methods:

• Assessing CF antigen stability through freeze-thaw cycles and storage.
• Determining viral infectivity and antigen titers post-infection.
• Estimating molecular weight using gel filtration.
• Analyzing polypeptide composition via SDS-PAGE electrophoresis.

Main Results:

• CMV CF antigen remained stable after multiple freeze-thaw cycles and two months of storage at 4°C.
• CF antigen was detectable as early as 24 hours post-infection, with rapid titer increases observed between days 3-6.
• Gel filtration estimated the CF antigen molecular weight to be >1.5 x 10^7 daltons.
• SDS-PAGE revealed two specific polypeptides in human CMV CF antigen preparations (140,000 and 66,000 daltons), with the smaller being glycosylated.
• A 66,000-dalton polypeptide was unique to human CMV, absent in murine CMV and herpes simplex virus type 1.

Conclusions:

• Human CMV CF antigen exhibits notable stability, making it suitable for diagnostic applications.
• The identified polypeptides, particularly the 66,000-dalton component, are specific markers for human CMV.
• These findings contribute to a deeper understanding of human CMV antigen structure and potential diagnostic targets.